Sign Out
Hypersensitivity to the active substance or to any of the excipients.
Patients with genetic defects affecting the methionine cycle and/or causing homocystinuria and/or hyperhomocysteinemia (e.g. cystathionine beta-synthase deficiency, Vitamin B12 metabolism defect).
Continue with Google